|
See related Buminate 25% infusion information |
|
|
|
Manufacturer |
Baxter Healthcare |
|
Distributor |
Zuellig |
|
Contents |
Human serum albumin |
|
Indications |
Hypovolemia, hypoalbuminemia due to burns, adult resp distress syndrome, nephrosis; cardiopulmonary bypass surgery, hemolytic disease of the newborn. |
|
Dosage |
Must be administered by IV inj. Max infusion rate: 1 mL/min. Hypovolemic shock Adult 100-200 mL. Childn 2.5-5 mL/kg body wt. May be repeated after 15-30 min if response is not adequate. Hypoalbuminemia Max daily dose: 2 g/kg body wt. Hemolytic disease of the newborn 1 g/kg body wt. |
|
Contraindications |
History of allergic reaction to albumin, severely anemic patients & patients w/ cardiac failure. |
|
Special Precautions |
A BP rise after infusion may require close observation of the injured or post-op patient to detect & treat severed blood vessels that may not have bled at a lower BP. |
|
Adverse Drug Reactions |
Occasionally fever, chills, nausea, urticaria.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Buminate 25% infusion |
|
Buminate 25% 25 % x 50 mL |
|
Buminate 25% 25 % x 100 mL |
|
|
|
Manufacturer: |
Baxter Healthcare |
|
Distributor: |
Zuellig
|
|
|
|
